|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01805232 |
|
Date of registration:
|
02/03/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Intravenous Artesunate and Malaria
IVAS |
|
Scientific title:
|
Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan |
|
Date of first enrolment:
|
March 2013 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01805232 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Sudan
| | | | | | | |
|
Contacts
|
|
Name:
|
Abzinab A Ali, MD |
|
Address:
|
|
|
Telephone:
|
+249911259199 |
|
Email:
|
ishagadamm@yahoo.com |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
severe P.falciparum malaria-
Exclusion Criteria:
mixed infection Pregnant women -
Age minimum:
1 Year
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Malaria
|
|
Intervention(s)
|
|
Drug: artesunate
|
|
Drug: Quinine
|
|
Primary Outcome(s)
|
|
clearance of the parasite and fever
[Time Frame: 3 days]
|
|
Secondary ID(s)
|
|
artesunate and malaria
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|